New Coronavirus Vaccine Advances to Phase 2 Human Trials

ExtremeTech

Published

US-based biotech firm Moderna says its initial human vaccine trials have been a success with all patients developing antibodies against the virus. 

The post New Coronavirus Vaccine Advances to Phase 2 Human Trials appeared first on ExtremeTech.

Full Article